Related Experiment Video
Updated: Feb 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition
Emanuele Giurisato1,2, Qiuping Xu2, Silvia Lonardi3
1Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy; emanuele.giurisato@manchester.ac.uk cathy.tournier@manchester.ac.uk.
Abstract:
Owing to the prevalence of tumor-associated macrophages (TAMs) in cancer and their unique influence upon disease progression and malignancy, macrophage-targeted interventions have attracted notable attention in cancer immunotherapy. However, tractable targets to reduce TAM activities remain very few and far between because the signaling mechanisms underpinning protumor macrophage phenotypes are largely unknown. Here, we have investigated the role of the extracellular-regulated protein kinase 5 (ERK5) as a determinant of macrophage polarity. We report that the growth of carcinoma grafts was halted in myeloid ERK5-deficient mice. Coincidentally, targeting ERK5 in macrophages induced a transcriptional switch in favor of proinflammatory mediators. Further molecular analyses demonstrated that activation of the signal transducer and activator of transcription 3 (STAT3) via Tyr705 phosphorylation was impaired in erk5-deleted TAMs. Our study thus suggests that blocking ERK5 constitutes a treatment strategy to reprogram macrophages toward an antitumor state by inhibiting STAT3-induced gene expression.
Insights
Targeting extracellular-regulated protein kinase 5 (ERK5) reprograms tumor-associated macrophages (TAMs) to an antitumor state. Blocking ERK5 inhibits signal transducer and activator of transcription 3 (STAT3) signaling, halting cancer growth.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Signaling
Background:
- Tumor-associated macrophages (TAMs) promote cancer progression, but effective targets to reduce their activity are limited.
- The signaling pathways dictating protumor macrophage phenotypes are not well understood.
- Macrophage-targeted therapies are a promising avenue in cancer immunotherapy.
Purpose of the Study:
- To investigate the role of extracellular-regulated protein kinase 5 (ERK5) in determining macrophage polarity.
- To explore ERK5 as a potential therapeutic target for reprogramming TAMs.
Main Methods:
- Utilized myeloid ERK5-deficient mice to assess the impact on carcinoma graft growth.
- Performed molecular analyses to investigate signaling pathways in ERK5-deficient TAMs.
- Examined the effect of targeting ERK5 on macrophage transcriptional profiles.
Main Results:
- Carcinoma graft growth was halted in myeloid ERK5-deficient mice.
- Targeting ERK5 in macrophages induced a transcriptional shift towards proinflammatory mediators.
- Activation of signal transducer and activator of transcription 3 (STAT3) via Tyr705 phosphorylation was impaired in ERK5-deleted TAMs.
Conclusions:
- ERK5 plays a crucial role in regulating macrophage phenotype.
- Blocking ERK5 can reprogram TAMs into an antitumor state.
- Inhibition of ERK5-STAT3 signaling presents a potential cancer treatment strategy.
More Related Videos
08:41Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
Related Concept Videos
Group Polarization
Feedback Inhibition
Molecular Shape and Polarity
Polar Coordinates
Enzyme Inhibition
Polarity of the Cytoskeleton